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Summary 
Alterations in the dopaminergic system have been implicated in both animal and human obesity. 
However, to date, a comprehensive model on the nature and functional relevance of this 
relationship is missing. In particular, human data remain equivocal in that seemingly inconsistent 
reports exist of positive, negative or even no relationships between dopamine D2/D3 receptor 
availability in the striatum and measures of obesity. Further, data on receptor availability have 
been commonly interpreted as reflecting receptor density, despite the possibility of an alternative 
interpretation, namely alterations in the basal levels of endogenous dopaminergic tone. Here, we 
provide a unifying framework that is able to explain the seemingly contradictory findings and 
offer an alternative and novel perspective on existing data. In particular, we suggest (i) a 
quadratic relationship between alterations in the dopaminergic system and degree of obesity, and 
(ii) that the observed alterations are driven by shifts in the balance between general dopaminergic 
tone and phasic dopaminergic signalling. The proposed model consistently integrates human data 
on molecular and behavioural characteristics of overweight and obesity. Further, the model 
provides a mechanistic framework accounting not only for the consistent observation of altered 
(food) reward–responsivity but also for the differences in reinforcement learning, decision-
making behaviour and cognitive performance associated with measures of obesity. 
 
Introduction 
Obesity is associated with prominent alterations in the dopaminergic system in both animals and 
humans [1]. However, human data remain equivocal in that seemingly inconsistent reports exist 
of positive, negative or even no relationships between dopamine D2/D3 receptor availability in 
the striatum and measures of obesity. Further, data on receptor availability have been commonly 
interpreted as reflecting D2/D3 receptor density, despite the possibility of an alternative 
interpretation, namely alterations in the basal levels of endogenous dopaminergic tone. Here, 
upon reviewing the existing data, we provide a unifying framework that is able to (i) explain the 
seemingly contradictory findings and (ii) offer an alternative perspective on the existing data. 
The main question posed by this review is thus the following: can the assumption of a quadratic 
relationship between dopaminergic tone and degree of obesity reconcile the conflicting results on 
postsynaptic dopaminergic signalling in human obesity? 
 
  
3 
 
Dopamine signalling 
Phasic and tonic dopamine signalling 
The dopaminergic system is composed of three main pathways in the brain (for an overview, see 
Fig. 1). Dopaminergic input arises from neurons in the substantia nigra pars compacta (SNpc) 
and the ventral tegmental area (VTA), both located in the midbrain. The nigrostriatal pathway 
(Fig. 1, 1) delivers dopaminergic input from the SNpc to the dorsal striatum. This pathway has 
mostly been associated with motor control and the formation of automatic stimulus–response 
links such as habits. Secondly, information within the mesolimbic pathway (Fig. 1, 2) travels 
from the VTA to the nucleus accumbens (NAcc) in the ventral striatum from where it is relayed 
to the limbic system, i.e. the amygdala, hippocampus and prefrontal cortex (PFC). Finally, the 
mesocortical pathway (Fig. 1, 3) provides direct dopaminergic input from the VTA to the frontal 
cortex. 
 
Figure 1. Schematic overview on the three main dopaminergic pathways in the human brain. 
 
 
 
Figure 2. Overview on central dopaminergic metabolism (simplified). DOPA, 
dihydroxyphenylalanine; DOPAC, dihydroxyphenylacetic acid; HVA, homovanillic acid; 
MHPG, 3-methoxy-4-hydroxyphenylglycol; VMA, vanillylmandelic acid. 
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Figure 3. Relationship between reported relative difference in binding potential (BP) and the 
relative difference in mean body mass index (BMI) between lean and obese group under study 
[36-40]. Mean BMI of the obese groups ranges from 36.1 to 51.2 kg/m2. 
 
Dopamine (DA) in the central nervous system (CNS) acts as both neurotransmitter and 
neuromodulator. These functions differ with respect to their time scale of action, local 
distribution of DA and their effects in the CNS. 
 
Phasic DA release, in keeping with DA's function as neurotransmitter, is fast (with a millisecond 
precision), is dependent upon DA neuron burst firing, acts almost exclusively on postsynaptic 
cells and is quickly removed from the synaptic cleft, apparently without diffusion into the 
adjacent space. Phasic burst spiking activity depends upon glutamatergic excitatory synaptic 
input [2]. In contrast, background tonic DA release, reflecting DA's role as a neuromodulator, is 
independent of DA neuron burst firing, is not limited to the synapse and acts on a longer time 
scale of minutes to hours. Normally, tonic DA release is under potent GABAergic inhibition [2, 
3], and spontaneous tonic spiking activity of VTA neuron populations determines the 
concentration of tonic extracellular DA [2]. 
 
Phasic DA release is triggered by behaviourally relevant stimuli, thereby serving as a learning 
and eventually prediction signal [4-6]. However, the intensity of phasic DA response can be 
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modulated by tonic DA release through an effect on extracellular DA levels [7]. Tonic DA 
activity has been demonstrated to be a potent inhibitor of phasic signals due to activation of 
release-regulating presynaptic autoreceptors [8-11]. Exogenous DA has been experimentally 
shown to hyperpolarize and eventually silence isolated dopaminergic neurons [12]. Importantly, 
tonic DA release at physiological levels may define the background level of DA receptor 
stimulation and availability at both the levels of autoreceptors and postsynaptic receptors [7]. 
Importantly, extrasynaptic tonic DA levels have been shown to exhibit slow but substantial 
alterations in response to drugs or stress [13]. Therefore, homeostatic processes induced by 
altered DA tone may contribute to a modulation of phasic DA responsivity. 
 
Alterations in the balance between tonic and phasic DA signalling have been described during 
adolescence and in psychiatric diseases such as schizophrenia and depression [7]. Adolescence is 
accompanied by increases in incentive–reward motivation, potentially mediated by an altered 
interplay between tonic and phasic modes of DA transmission [14]. In schizophrenia, abnormally 
large responses to phasic DA release are suggested to be induced by a reduced overall DA tone 
[7, 15], caused by a reduction of excitatory afferent input from hippocampus and PFC to the 
ventral striatum [2]. Here, we hypothesize that the opposite may be true for severe obesity, 
namely that abnormally small responses in phasic DA release might be paralleled by an overall 
increased DA tone. 
 
Dopaminergic signalling and subjective reward 
With the introduction of optogenetic techniques, it is feasible to manipulate the firing properties 
of DA neurons, and hence the tonic and phasic release of DA, in a highly controlled fashion in 
freely behaving animals. Phasic, unlike tonic, light-activated stimulation of VTA DA neurons 
results in a transient release of DA in the ventral striatum in vivo. Animals develop a preference 
for a chamber associated with phasic DA neuron stimulation over a chamber associated with 
tonic DA neuron stimulation [16], which is illustrative of the rewarding properties of phasic DA 
release. Similarly, phasic stimulation of VTA DA neurons was shown to positively reinforce 
actions associated with delivery of food. Interestingly, such actions were not reinforced in the 
absence of food delivery [17]. These results suggest that phasic stimulation of DA neurons 
modulates reward-related learning and can specifically impact on food-seeking behaviour. While 
phasic firing of DA neurons thus may signal the arrival of reward, tonic firing of the same 
neurons is thought to subserve motivational states [18]. For example, in DA transporter knock-
down mice, chronically elevated extracellular DA facilitates ‘wanting’ and learning of an 
incentive motivation task for a sweet reward [19], whereas the general ‘liking’ of food 
reinforcers seems to be mostly unaffected by changes in DA tone [20]. Thus, individuals with 
increased dopaminergic tone might attribute higher incentive salience to rewarding stimuli. 
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Further, it has been shown for drugs of abuse that the subjective perception of reward depends 
upon the ability to induce a fast and steep increase in phasic striatal DA release [21]. Drugs that 
are more potent in this regard are classified as being more addictive. Further, the kinetics of the 
drug determine the intake frequency: drugs with a slower clearance are consumed less frequently 
compared with drugs that are cleared faster [22]. The obese state is accompanied by a reduced 
phasic DA release in the striatum in response to pharmacological [23] or glucose challenge [24], 
and unexpected taste rewards [25], an effect that may depend upon dietary fat content [26]. 
Importantly, the observation of reduced phasic DA release indicates less subjective reward in 
obese subjects. From this, the ‘reward-deficiency hypothesis’ for obesity has been derived, 
stating that obese subjects overeat to compensate for a reduced feeling of subjective reward from 
food [27], caused by attenuated phasic dopaminergic signalling. 
 
Obesity and the dopaminergic system 
The following paragraphs will review and interpret existing human data, analysing obesity-
associated differences in essential factors controlling dopaminergic tone and phasic 
dopaminergic responses. 
 
Phasic dopaminergic transmission and basal dopaminergic tone depend upon various factors 
such as DA synthesis capacity, stipulated by levels of DA precursors, the density and availability 
of DA receptors, the activity and level of dopamine transporter (DAT), which defines the rate of 
DA removal from the synaptic cleft in the striatum, and enzymes involved in the synthesis 
(tyrosine hydroxylase) and degradation of DA in prefrontal areas, such as catechol-O-methyl 
transferase and monoamine oxidase. In humans, some of these components can be measured 
either indirectly by molecular neuroimaging or by determining the level of the metabolites of DA 
in the cerebrospinal fluid (CSF), blood or urine. 
 
Several alterations within the dopaminergic system have been observed in overweight and obese 
subjects. Most prominent are reports on altered striatal D2/D3 receptor availability and 
functional differences in the striatum, e.g. DA release. However, some studies have also 
addressed a differential level in DA metabolites. 
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Catecholamine metabolites (homovanillic acid, vanillylmandelic acid, 3-methoxy-4-
hydroxyphenylglycol, dihydroxyphenylacetic acid) 
Adult obese subjects have been reported to have higher levels of homovanillic acid (HVA) in the 
CSF [28]. HVA measured in the CSF, blood or urine is DA's main catabolite and is suggested to 
reflect the central dopaminergic turnover and tone [29], while peripherally measured DA is 
unlikely to reflect the centrally synthesized DA because DA itself cannot cross the blood–brain 
barrier. Central DA is synthesized from dihydroxyphenylalanine (DOPA) and is further 
metabolized to noradrenaline and adrenaline (see Fig. 2). Its degradation leads to the catabolites 
dihydroxyphenylacetic acid (DOPAC) and eventually HVA. Degradation of noradrenaline leads 
to 3-methoxy-4-hydroxyphenylglycol (MHPG) and vanillylmandelic acid (VMA), and the 
degradation of adrenaline to VMA. These catabolites can be measured peripherally, i.e. directly 
in the blood or after clearance by the kidneys in the urine. 
 
Further, obese children show significantly increased urinary levels of HVA and MHPG 
compared with normal controls and a nominally increased secretion of DOPAC [30]. This 
indicates that obesity might be paralleled by increases in tonic DA as a result of increased 
synthesis or turnover. 
 
In contrast, malnourished individuals with anorexia nervosa show reduced levels of HVA in the 
CSF, an effect that even persists after recovery [31]. Taken together, these results indicate that 
weight status in general might be associated with altered dopaminergic tone in the CNS. 
Interestingly, patients suffering from Prader–Willi syndrome, a rare genetic disorder that is 
linked to severe hyperphagia, also show increased levels of HVA in the CSF independent of 
body mass index (BMI) [32]. This finding supports the notion that dopaminergic tone might be 
associated with characteristics of eating behaviour, or dietary content, rather than weight status 
per se. 
 
Dopamine release, dopamine reuptake and dopaminergic tone via dopamine transporter 
Rodent studies suggest that there might be an increase in striatal extracellular DA following 
prolonged high fat intake or diet-induced obesity (DIO) [26, 33]. This has been ascribed in part 
to a reduced rate of DA reuptake in the striatum, as has been demonstrated in non-obese animals 
that have been fed a high-fat diet (HFD) for 6 weeks when compared to animals receiving a low-
fat diet [26]. Reduced uptake is thought to be mediated by either disturbed trafficking or post-
translational modifications of the DAT protein in non-obese HFD rats [26], or its reduced 
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production in DIO rats [33]. In humans, however, there seems to be no reliable association 
between obesity and DAT availability [34, 35]. 
 
D1, D2/D3 receptors 
While human studies on the relationship between D1 receptors and obesity are missing so far, 
several studies have addressed the relationship between D2/D3 receptor availability and obesity. 
However, studies investigating the binding potential (BP) of D2/D3 receptors provide seemingly 
contradictory results. Wang et al. and de Weijer et al. both found lower striatal availability of 
D2/D3 receptors in obese subjects using [11C]raclopride with positron emission tomography 
(PET) and [123I]IBZM with single photon emission computed tomography (SPECT), 
respectively [36, 37]. In contrast, Guo et al. found that BP in caudate and putamen is actually 
higher in subjects with obesity when using [18F]fallypride, while there was no difference in the 
NAcc [38]. Dunn and colleagues also used [18F]fallypride to determine D2/D3-receptor BP in 
lean and obese women [39]. Their study also revealed higher BP in the caudate for obese women 
compared with their lean counterparts. Two studies reported no difference in BP between lean 
and obese subjects [40, 41]. Karlsson and colleagues also used [11C]raclopride, while Eisenstein 
and colleagues used [11C]NMB, a D2-receptor-specific compound that cannot be replaced by 
endogenous DA [40]. 
 
Interestingly, Guo and colleagues reported an association of BP and characteristics of eating 
behaviour, namely ‘opportunistic eating’, even when controlling for BMI. They identified 
positive associations with ‘opportunistic eating’ in dorsal and lateral striatum and a negative 
association in the ventromedial striatum [38]. This supports the notion of a relationship between 
BP and eating behaviour rather than BMI alone. Further, women who recovered from anorexia 
nervosa had a significantly increased BP using [11C]raclopride in the antero-ventral striatum 
compared with control women without a history of anorexia [42]. As [11C]raclopride competes 
with endogenous DA, this result is suggestive of lower dopaminergic tone in formerly anorectic 
women. Further, this finding fits well with the observation of lower levels of dopamine's main 
catabolite HVA in women who recovered from anorexia nervosa compared with control women 
[31]. 
Can the results be ascribed to receptor density or dopaminergic tone? 
Importantly, depending upon the tracer used, BP does not directly reflect the density of DA 
receptors but rather is a measure of receptor availability. The number of available, i.e. free, 
receptors depends upon the total number of receptors and their rate of occupancy. Hence, under 
the assumption of a relatively constant receptor density with an altered dopaminergic tone, in 
some cases a lower BP can be observed as receptors are competed for by endogenous dopamine. 
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For example, this was shown in the dorsal striatum in a study of lean individuals treated with 
[11C]raclopride and scanned before and after a meal [43]. 
 
All studies that report a difference in BP used compounds that are not specific for D2-receptors 
but bind also to D3-receptors, and, importantly, can be displaced by endogenous DA (see Table 1 
for details). One study that showed no differences in BP used a D2-specific tracer, which in 
addition cannot be competed for by endogenous dopamine. Taken together, these results leave 
open two alternative ways of interpreting the data: either the observed effects can be driven by 
alterations in D3-receptor availability, or by an altered level of endogenous DA in obese 
subjects. Due to the comparably low expression levels of D3Rs when compared to D2Rs [44], it 
seems unlikely that the effect would be mainly driven by altered D3R density. Dunn and 
colleagues discussed the possibility of altered endogenous DA levels in obese subjects when 
interpreting their data. Their study is the only one that exclusively measured subjects in the early 
evening (starting at 18:30) after an 8.5-h fast. Interestingly, obese subjects had lower levels of 
ghrelin compared with lean subjects directly prior to the scanning session. This is important 
because BP correlated negatively with ghrelin levels. Ghrelin has been shown to increase VTA 
DA neuron firing and tonic (but not phasic) accumbal DA release, i.e. extracellular DA levels 
[45-47]. Therefore, the difference between lean and obese groups in the study of Dunn and 
colleagues could have been induced by a differential physiological reaction in terms of ghrelin-
mediated DA release to the 8.5-h fasting period directly before scanning. In the remainder of the 
studies, nutritional status and scan condition with respect to time of day are heterogeneous 
between studies and even study groups (see Table 1). As nutritional status may influence D2R 
availability due to dopamine release, the discussion of a potential impact of variance in this 
variable on the seemingly conflicting results on the association between D2R availability and 
overweight or obesity is difficult. 
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Table 1. Study and participant characteristics of human studies comparing striatal binding 
potential (BP) between lean and obese groups 
Study Wang 
et al. [36] 
de 
Weijer 
et al. 
[37] 
Dunn 
et al. [39] 
Guo et al. 
[38] 
Karlsson 
et al. [41] 
Eisenst
ein 
et al. 
[40] 
Main finding Lower 
D2/D3 BP 
in obese 
subjects 
Lower 
D2/D3 
BP in 
obese 
subjects 
Higher 
D2/D3 BP 
in obese 
subjects 
Higher 
D2/D3 BP 
in obese 
subjects 
No 
differences 
in D2/D3 
BP 
No 
differen
ces in 
D2 BP 
Tracer [11C]raclo
pride 
[123I]IB
ZM 
[18F]fallyp
ride 
[18F]fallyp
ride 
[11C]raclo
pride 
[11C]N
MB 
BMI lean 24.7 (2.6) 
21–28 
21.7 
(2.1) 
19.5–
27.6 
23 (2) 22.4 
(21.3–
23.49) CI 
22.65 
(2.94) ns 
22.6 
(2.2) 
BMI obese 51.2 (4.8) 
42–60 
46.8 
(6.5) 
38.7–
61.3 
40 (5) 36.1 
(33.96–
38.3) CI 
41.89 
(3.88) 
37.1–49.3 
40.3 
(4.9) 
Age lean 37.5 (5.9) 
25–45 
28 (10.4) 
20–60 
40 (9) 28 (25.1–
30.4) CI 
44.86 
(12.88) 
29.7 
(5.6) 
Age obese 38.9 (7.3) 
26–54 
37.8 (7) 
26–49 
40 (8) 35 (31.9–
38.8) CI 
39.08 
(10.74) 
32.5 
(5.9) 
Ethnicity lean 
(black/white/His
panic) 
ns ns 1/7/0 ns ns. 1/14/0 
Ethnicity obese 
(black/white/His
panic) 
ns ns 5/9/0 ns ns 6/8/1 
Males/females 
lean 
7/3 0/15 0/8 12/11 0/14 4/11 
Males/females 
obese 
5/5 0/15 0/14 10/10 0/13 3/12 
Scan condition 
lean 
About 
11:00 am 
after 
overnight 
fast 
At 
various 
times of 
day 
6:30 pm 
after 8.5 h 
fasting, 
standard 
BF and 
meal 
before 
10:00 am 
Morning 
after 
standard 
BF 
Not 
specified, 
after 2 h 
fasting 
Not 
influenti
al 
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Scan condition 
obese 
About 
11:00 am 
after 
overnight 
fast 
After 
overnigh
t fast in 
the 
morning 
6:30 pm 
after 8.5 h 
fasting, 
standard 
BF and 
meal 
before 
10:00 am 
Morning 
after 
standard 
BF 
Not 
specified, 
after 2 h 
fasting 
Not 
influenti
al 
Main finding Lower 
D2/D3 BP 
in obese 
subjects 
Lower 
D2/D3 
BP in 
obese 
subjects 
Higher 
D2/D3 BP 
in obese 
subjects 
Higher 
D2/D3 BP 
in obese 
subjects 
No 
differences 
in D2/D3 
BP 
No 
differen
ces in 
D2 BP 
BMI, body mass index; BF, breakfast; CI, confidence interval; ns, not specified. 
Taken together, altered dopaminergic tone seems to be a plausible explanation of the observed 
effects. However, an influence of differences in D2/D3 receptor density cannot be excluded. 
 
Is dopaminergic tone dependent upon the level of obesity? 
Comparing the BMI range of the obese groups across all studies reveals profound differences 
between studies. Mean BMI of the obese group in the studies of Wang and colleagues and De 
Weijer and colleagues was higher than in the studies of Dunn et al., Eisenstein et al., Karlsson 
et al. and Guo et al. (for study characteristics, see Table 1). To test the hypothesis that BMI might 
influence BP in the overweight to obese range of body weight, potentially induced by alterations 
in DA tone, the relative difference in BP between lean and obese groups for all studies reported 
above was plotted against the relative difference in BMI between lean and obese controls for 
each study. A linear association would indicate a dependency between dopaminergic tone and 
grade of obesity. As shown in Fig. 3, indeed, there was a linear relationship, starting with higher 
levels of availability (interpreted as lower DA tone) in the moderately obese range and then 
quickly transitioning into profound reductions in availability (interpreted as higher DA tone) in 
the morbidly obese range. 
 
The assumption of a linear relationship between markers of human obesity and dopaminergic 
tone is further supported by correlational analyses performed within the obese group in the study 
of Wang and colleagues [36]. They observed a significant negative relationship between BMI 
and BP in severely obese subjects but not in the group of lean subjects (Fig. 4b). Conversely, 
Cosgrove et al. recently observed a positive relationship between BP and BMI in a group of 
normal weight to moderately obese subjects [48] (Fig. 4a; BMI 21.5–36.5 kg m−2). Taken 
together, these data point to a non-linear quadratic relationship between BP and BMI with higher 
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BP in the lower ranges of obesity and lower BP with more severe obesity. The observations of 
Kessler and colleagues corroborate our interpretation of the data: while they observed small 
negative relationships between BP and BMI in mildly obese subjects, they found a strong 
positive association between BMI and DA release in the striatum and SN [49]. This observation 
would be in line with a BMI-dependent decrease of tonic DA that boosts phasic DA signalling in 
the mildly obese range. 
 
 
Figure 4. Different linear relationships between body mass index (BMI) and dopamine receptor 
availability. (a) Positive association between receptor availability and BMI in moderately obese 
subjects from the study of Cosgrove et al. [48]. (b) Negative association between receptor 
availability (Bmax/Kd) and BMI in severely obese subjects from the study of Wang et al. [36]. 
 
The proposed quadratic changes in DA tone that takes place with the progression of obesity from 
none, to mild, to severe is potentially paralleled by changes in other BMI-dependent tonic 
signalling molecules such as insulin and leptin. For example, the adipokine leptin circulates in 
proportion to adiposity and inhibits VTA DA neurons and DA release [50, 51]. Therefore, a 
higher BMI could be associated with higher levels of leptin and decreased tonic DA until a 
‘break-point’ is reached when leptin resistance develops and progressively worsens, resulting in 
an escalation in DA tone. However, Guo and colleagues [38] argued that endogenous DA 
occupies only about 10% of DA receptors, thus alterations in endogenous DA may not fully 
explain the observed changes in DA receptor availability associated with overweight and obesity 
which are bigger in magnitude. Further, as opposing relationships between DA receptor 
availability in different parts of the striatum have been reported [38], the seemingly contradictory 
observations in the studies reviewed earlier might in part also be ascribed to variance in region of 
interest (ROI) selection across studies and averaging over the whole striatum. 
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In summary, differences in tonic endogenous DA levels between lean and obese subjects could 
be the main driver of group differences in studies using tracers that can be displaced by 
endogenous DA. Furthermore, a quadratic relationship between DA tone and degree of obesity is 
able to reconcile the seemingly conflicting results. 
 
If there is indeed an increase in tonic DA signalling in morbid obesity, would this result in the 
recruitment of extra-synaptic DA receptors? It appears at least from a recent PET study on 
humans that [11C]raclopride binds to an appreciable level of extra-synaptic D2Rs [52]. This 
raises the tantalizing possibility that the findings from Wang et al. are a result of decreased 
occupancy of extra-synaptic D2Rs as a consequence of increased tonic DA signalling. 
 
Human model and implications 
Suggested human model 
Our main hypothesis is that overweight/mild obesity and severe obesity are associated with 
different states of dopaminergic tone: overweight may be paralleled by a reduction in 
dopaminergic tone and associated exaggerated phasic DA responses in the striatum. On the 
contrary, severe obesity may be characterized by an increased dopaminergic tone with associated 
blunted striatal DA burst firing. Importantly, these two states would lead to differential 
predictions regarding reward sensitivity and cognitive functioning. As we built our model on 
data exclusively obtained in the striatum, it is likewise possible that alterations in DA tone are 
restricted to the striatum or also pertain to other structures with dopaminergic input, e.g. the PFC. 
 
Reward sensitivity and dopamine tone 
An inverted u-shape has been proposed for the relationship between the sensitivity and 
responsiveness to reward and markers of obesity [53, 54]. This is consistent with parallel 
associations between tonic DA levels and degree of obesity, if the reference BP in lean subjects 
is additionally taken into account (Fig. 5). Higher reward sensitivity in the overweight/mildly 
obese state would thus be associated with lower DA tone and higher phasic DA responses. On 
the contrary, higher tonic DA level with higher BMI would thus be associated with lower reward 
sensitivity, induced by a down-regulation of phasic DA responses. 
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Figure 5. Inverted U-shaped relationships in reward sensitivity and dopaminergic tone. Davis 
and Fox (a) as well as Dietrich, Federbusch and colleagues (b) reported a quadratic relationship 
between different measures of reward sensitivity and body mass index (BMI). The characteristics 
of this relationship match the here-proposed quadratic relationship between dopamine tone and 
BMI (c). Control: reference binding potential (BP) of lean groups. Light grey dot: study of 
Eisenstein and colleagues, who used a tracer that is not displaceable by endogenous dopamine. 
Labels refer to first author and year of publication of the respective study. 
 
Differential impact of tonic and phasic dopaminergic signals on reinforcement learning 
Reinforcement learning depends upon both positive and negative learning signals, the so-called 
prediction errors (PEs): positive PEs, i.e. when an outcome is better than expected, are paralleled 
by an increase in phasic DA levels. Negative PEs, i.e. signalling that an outcome is worse than 
expected and behaviour should subsequently be adapted, are paralleled by a dip in tonic 
dopaminergic firing rate [5]. Recently, it has been shown in healthy, normal-weight volunteers 
that learning from negative outcomes is associated in an inverted u-shaped manner with D2/D3 
receptor availability in the striatum [55]. As variation in D2/D3 receptor density is likely to be 
limited in healthy volunteers, availability may likewise have been dependent upon dopaminergic 
tone in this study. Thus, one might hypothesize that obesity-associated alterations in 
dopaminergic tone should be also paralleled by specific alterations in learning from positive and 
negative feedback with increasing degree of obesity. Indeed, this has been observed in different 
paradigms: Mathar and colleagues observed in moderately obese subjects a specific impairment 
in learning from negative PEs in a probabilistic classification paradigm while learning from 
positive PEs was unaffected (D Mathar, J Neumann, A Villringer A, A Horstmann, unpublished 
data). This impairment was paralleled by differences in functional connectivity between the 
ventral striatum and premotor and motor cortices. In line, Coppin and colleagues observed 
deficits in negative but not positive outcome learning when comparing moderately obese subjects 
to normal-weight control subjects [56]. 
 
15 
 
Cognition and dopamine 
Dopaminergic tone is important not only for reward and learning but also for performance in 
several cognitive domains, most prominently in tasks requiring working memory [57]. The 
influence of dopaminergic transmission on performance has been shown to be variable and is 
probably domain-specific. Early work has indicated an ‘inverted u-shaped’ function for working 
memory, i.e. that either too much or too little dopaminergic transmission in the PFC impaired 
working memory performance in rats [58]. Obesity has been associated with impairments in 
working memory [59, 60], although findings remain equivocal [60]. Interestingly, Coppin and 
colleagues [56] reported impairments in both overweight and obese subjects compared with 
normal-weight controls with a nominally more pronounced effect in overweight (mean BMI 
27.6 kg/m2) compared with mildly obese (mean BMI 36 kg/m2) subjects. These data might hint 
at a dynamic and quadratic relationship between degree of obesity and performance on a working 
memory task, possibly mediated by parallel changes in DA tone. Because of the inverted u-
shaped function for DA tone and working memory performance, both lower and higher DA tone 
would result in impairments in working memory. 
 
Recent work proposes several other dependencies between dopaminergic tone and performance 
in different cognitive domains [61]. For example, dopaminergic tone in the PFC has been 
suggested to be associated with cognitive flexibility [61]: a low tone is suggested to underpin 
heightened flexibility, while a high tone mediates lowered behavioural flexibility. Hence, 
following from our proposed model, behaviour in overweight and mild obesity should be 
characterized by increased flexibility, while severe obesity should be paralleled by a certain 
rigidity of behaviour. Indeed, in a lever-pressing task conducted on severely obese rats with 
restricted access to a palatable food, behavioural rigidity was induced and alleviated when a DA 
receptor antagonist was administered into the striatum [62]. Further, increasing levels of obesity 
were associated with heightened habitual responding in a classical sensory devaluation task in 
obese men [63]. Although it has been proposed that striatal and PFC DA tone are related in a 
reciprocal manner under normal conditions [64], this might no longer be the case in obesity. 
Thus, the balance between striatal and PFC signalling might be disturbed by a general increase in 
DA tone. 
 
Conclusion 
The assumption of non-linear changes in the general DA tone over the spectrum of overweight 
and obesity leads to the hypothesis that feedback-dependent behaviour, i.e. reactions to reward 
and punishment, as well as different domains of cognition may be differentially affected in 
different stages of developing obesity. Further, alterations of dopaminergic tone with increasing 
states of obesity might be regarded as disturbances of dopaminergic regulation rather than 
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deficits in DA transmission, comparable to conditions such as schizophrenia or affective 
disorders [13]. Overweight and mild obesity may be paralleled by a reduction in dopaminergic 
tone and associated exaggerated phasic DA responses in the striatum. Severe obesity, in contrast, 
may be characterized by an overall increased dopaminergic tone with associated blunted striatal 
DA burst firing. This should be taken into account when designing pharmacological therapies in 
obesity, e.g. targeting the dopaminergic system. Further, looking for quadratic associations in 
samples spanning mild to severely obese subjects might reveal compatible patterns in cognition. 
The failure to do so might have contributed to the lack of homogeneous associations between 
performance in several cognitive domains and obesity [60]. 
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